Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

The study created a new method to test drugs that affect hormone processing in skin.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

Estrogen affects how vitamin A is processed in mouse skin, which may impact acne treatment, hair growth, and skin defense.

Isotretinoin shrinks sebaceous glands without affecting hair or skin color, unlike etretinate.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Clascoterone 1% cream is a promising new treatment for acne.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

The right amount of retinoic acid is essential for normal hair growth and development.

Isotretinoin at a low dose for three months does not significantly affect hair growth.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ruxolitinib cream may help treat severe hair loss in children.

New treatments for skin diseases in 1979 showed promising results with fewer side effects.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

The 1927 nm Thulium laser effectively and safely treats postinflammatory hyperpigmentation in darker skin tones.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

Topical tacrolimus is effective and safe for treating alopecia areata.

Low-dose isotretinoin and erythromycin effectively treated hair loss in two young sisters.

Clascoterone cream could be used for other skin conditions affected by hormones.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.